EDITORIAL

HIV Treat Bull - Vol. 7, No. 5, May 2006

Included in this issue is Sir Liam Donaldson’s letter recommending PEP after non-occupational exposure as part of our national HIV prevention strategy in which he asks chief executives of all primary care trusts to “ensure that PEP is part of the spectrum of sexual health services for your local population.” We welcome this directive from the Department of Health but must reiterate our comment that this is more likely to have been driven by a legal challenge than by the recent publication of the BASHH guidelines on the use of PEPSE. The letter and guidelines must be widely publicised as (and we quote from a BHIVA presentation), “PEP can only work if people know about it.”

We also include our first reports from the recent BHIVA conference in Brighton. These include a report in which it was found that almost 60% of symptomatic acute HIV presentations in a primary healthcare setting were missed by GPs, and a report on B-5701 testing to reduce incidence of abacavir hypersensitivity reaction.

Our other conference reports are the final group from CROI. These include studies from resource limited settings which had a high profile at the meeting. Reports include treatment durability and toxicities, mortality risk and HIV associated illness in the first few months from initiating therapy and scale up of treatment. There was much debate in these sessions including around payment for treatment, so it was welcome to hear champion of public health, Tony Harries from Malawi, state the obvious that healthcare and treatment “must be free”. We have never been sure why this must be debated at all.

2008-03-10
IB060705-01

©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.